Browse > Article
http://dx.doi.org/10.5012/bkcs.2004.25.4.506

Synthesis of [18F]Fluorocholine Analogues as a Potential Imaging Agent for PET Studies  

Yu, Kook-Hyun (Department of Chemistry, Dongguk University)
Park, Jeong-Hoon (Department of Chemistry, Dongguk University)
Yang, Seung-Dae (Cyclotron Application Laboratory, Korea Cancer Center Hospital)
Publication Information
Abstract
There have been intensive studies concerning $[^{11}F]$choline ($[^{11}F]$methyldimethyl( ${\beta}$ -hydroxyethyl) ammonium) (1) which is known as a very effective tracer in imaging various human tumors localized in brain, lung, esophagus, rectum, prostate and urinary bladder using Positron Emission Tomography (PET) and there is increasing interest in $^{18}F$ labelled choline (2) and proved to be useful to visualize prostate cancer. We have prepared six $^{18}F$ labelled alkyl choline derivatives (3a-3c, 4a-4c) from ditosylated and dibrominated alkanes in moderate yields. The six alkyl tosylate or bromate ammonium salts have been synthesized as precursors. Radiofluorination was achieved by the treatment of precursors with $^{18}F$ - in the presence of Kryptofix-2.2.2.. The labeling yields varied ranging from 7 to 25%.
Keywords
Positron Emission Tomography (PET); $[^{18}F]$Fluorocholine derivatives;
Citations & Related Records

Times Cited By Web Of Science : 6  (Related Records In Web of Science)
Times Cited By SCOPUS : 7
연도 인용수 순위
1 Yu, K. H.; Kim, Y. S.; Kim, S. W.; Park, J. H.; Yang, S. D.;Herdering, W.; Knoechel, A. J. Labeld. Compds. Radiopharm.2003, 29, 1151.
2 Ishidate, K. Choline Transport and Choline Kinase inPhosphatidylcholine Metabolism; Vance, D. E., Ed.; CRC press:Boca Raton, Florida, 1989; pp 9-32.
3 Degrador, T. R.; Coleman, R. E.; Wang, S.; Baldwin, S. W.; Orr,M. D.; Robertson, C. N.; Polascik, T. J.; Price, D. T. Cancer Res.2001, 61, 110.
4 Yang, S. D.; Kim, S. W.; Suh, Y. S.; Chun, K. S.; Ahn, S. H.; Hur,M. G.; Lim, S. M.; Hong, S. W.; Yu, K. H. The Kor. J. Nucl. Med.2001, 35, 185.
5 Hara, T.; Kosaka, N.; Shinoura, N.; Kondo, T. J. Nucl. Med. 1997,38, 842.
6 Hara, T.; Kosaka, N.; Kishi, H. J. Nucl. Med. 1998, 39, 990.
7 Oh, S. J.; Choe, Y. S.; Kim, S. E.; Choi, Y.; Lee, K. H.; Kim, B.-T.Bull. Korean Chem. Soc. 2000, 21, 1162.
8 Hara, T.; Kosaka, N.; Kishi, H. J. Nuc. Med. 2002, 43, 187.
9 Coleman, R. E.; Degrador, T. R.; Wang, S.; Baldwin, S. W.; Orr,M. D.; Reiman, R.; Price, D. T. Clin. Positron Imaging 2000, 3,147.   DOI   ScienceOn
10 Hara, T.; Yuasaa, M. Appl. Radiat. Isot. 1999, 50, 531.   DOI   ScienceOn
11 Iwata, R.; Pascali, C.; Bogni, A.; Furumoto, S.; Terasaki, K.;Yanai, K. Appl. Radiat. Isot. 2002, 57, 347.   DOI   ScienceOn
12 Friedland, R. P.; Mathis, C. A.; Budinger, T. F.; Moyer, B. R.;Rosen, M. J. Nucl. Med. 1983, 24, 812.
13 Armiger, H.; Sommers, H.; Barnes, J. D. J. Am. Chem. Soc. 1957,79, 3491.   DOI
14 Degrador, T. R.; Coleman, R. E.; Baldwin, S. W.; Price, D. T.; Orr, M. D.; Wang, S. US patent 2002/0061279.